Needham analyst Mayank Tandon kept his Buy rating and $68 price target on ExlService after the company's conference call about its acquisition of SCIO Health Analytics, saying the deal should add over $80M in annual healthcare analytics revenue to the company. While pressuring operating margins in the near term, Tandon notes the deal will be neutral to expected 2018 EPS and become earnings accretive in 2019. The analyst contends that ExlService is a "solid long-term holding" for investors looking for exposure to business process outsourcing amid healthy industry demand and its "strong vertical capabilities".